ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 158 filers reported holding ANIKA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $291,000 | -58.6% | 8,128 | -50.8% | 0.02% | -56.9% |
| Q3 2021 | $703,000 | -0.8% | 16,509 | +0.8% | 0.05% | +8.5% |
| Q2 2021 | $709,000 | +1.3% | 16,381 | -4.6% | 0.05% | -6.0% |
| Q1 2021 | $700,000 | +125.1% | 17,164 | +174.5% | 0.05% | +400.0% |
| Q1 2018 | $311,000 | -51.1% | 6,252 | -47.0% | 0.01% | -44.4% |
| Q4 2017 | $636,000 | -19.4% | 11,800 | -13.2% | 0.02% | -30.8% |
| Q3 2017 | $789,000 | +17.6% | 13,600 | 0.0% | 0.03% | -3.7% |
| Q2 2017 | $671,000 | -9.7% | 13,600 | -20.5% | 0.03% | -30.8% |
| Q1 2017 | $743,000 | -32.3% | 17,107 | -23.6% | 0.04% | -45.8% |
| Q4 2016 | $1,097,000 | +1.5% | 22,400 | -0.9% | 0.07% | +14.3% |
| Q3 2016 | $1,081,000 | -10.8% | 22,600 | 0.0% | 0.06% | -34.4% |
| Q2 2016 | $1,212,000 | +25.2% | 22,600 | -4.1% | 0.10% | +317.4% |
| Q1 2014 | $968,000 | +75.0% | 23,557 | +62.5% | 0.02% | -65.7% |
| Q4 2013 | $553,000 | -63.3% | 14,501 | -77.0% | 0.07% | +63.4% |
| Q3 2013 | $1,508,000 | – | 62,918 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
| AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
| CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
| TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
| Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
| OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
| Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
| THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
| DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |